• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Dr Rajiv Agarwal

Dr. Rajiv Agarwal is a practicing nephrologist and a tenured Professor of Medicine at Indiana University School of Medicine at Indianapolis, IN. Dr. Agarwal earned his medical degree from the All India Institute of Medical Sciences in New Delhi.  After completing residency in Internal Medicine at the same institution he completed a Nephrology fellowship at University of Texas, Southwestern Dallas. In July 1997, he joined Indiana University as Clinical Assistant Professor and within 10 years was promoted to the rank of full Professor. Dr. Agarwal has published > 250 original papers and reviews in Nephrology.  Dr. Agarwal has received the Indiana University Trustee’s teaching award, the young scholar award of the American Society of Hypertension, and the Clinical Excellence award from the American Nephrologists of Indian Origin (ANIO).  He serves on the Editorial Board of several nephrology journals and as an Editor for Nephrology Dialysis Transplantation and the American Journal of Nephrology.  He also served as an Associate Editor of NephSAP and the Journal of the American Society of Hypertension. He has had numerous invited lectures nationally and internationally.

Dr. Agarwal is an internationally recognized leader in the area of clinical and translational research in nephrology.  He had chaired numerous event adjudication committees of trials related to diabetic nephropathy and developed methods to adjudicate end stage renal disease in this difficult group of patients.  With funding from the National Institutes of Health he has recently uncovered through a randomized clinical trial the ill effects of parenteral iron in CKD.  His foremost contribution has been in the area of hypertension in hemodialysis patients for which he has been funded since 2003 by the National Institutes of Health.  He has refined the techniques to diagnose and treat hypertension in this complex group of patients and performed important randomized trials in this difficult group of patients. He has been federally funded since 2009 by the Veterans Administration and for uncovering the prevalence and mechanisms of masked hypertension in chronic kidney disease.

« Professor Lars Wallentin
Dr Julian Gillmore »

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info